No Data
No Data
Centessa Pharmaceuticals Insider Sold Shares Worth $681,576, According to a Recent SEC Filing
Piper Sandler Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Maintains Target Price $38
Centessa Pharmaceuticals (CNTA) Gets a Buy From TD Cowen
Piper Sandler Initiates Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Announces Target Price $38
Morgan Stanley Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Maintains Target Price $27
Morgan Stanley Remains a Buy on Centessa Pharmaceuticals (CNTA)